Diridavumab Uses, Dosage, Side Effects and more
Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).
| Trade Name | Diridavumab |
| Generic | Diridavumab |
| Diridavumab Other Names | Diridavumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
